Author

Heather A. Wakelee

Stanford MedicineORCID 0000-0003-1136-980XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1 Research Focus:host-pathogen & immune response· 1 Assay:scATAC-seq· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Martinez-Lopez· 1 shared Abraham L. BayeriD· 1 shared Amaya VirósiD· 1 shared Angeliki MalliriiD· 1 shared Arianna MarinelloiD· 1 shared Benjamin BesseiD· 1 shared Bruce Xu· 1 shared Colin R. LindsayiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Martinez-Lopez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyCirculation ResearchPeer-reviewedFeb 11, 2025

A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated Myocarditis

Yuhsin Vivian Huang, Yin Sun, Harrison Chou…·Han Zhu

This study identifies CXCR3-CXCL9/10 axis as a therapeutic target for ICI-mediated myocarditis using mouse models and human patient data.

53 citationstop 1%

𝕏 PostBluesky

Cancer BiologyMolecular CancerPeer-reviewedNov 12, 2024

The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer

William J. McDaid, L. Wilson, Helen Adderley…·Angeliki Malliri

This study compares KRASG12C and KRASG12D mutant NSCLC models, finding that KRASG12D relies more on the PI3K-AKT-mTOR pathway, suggesting tailored combination therapies.

47 citationstop 3%

mousebulk RNA-seq

𝕏 PostBluesky